
Reset all filters
01 3Alexion Pharma Canada, AstraZeneca Rare Disease
Reset all filters
01 32942165
Reset all filters
01 3RAVULIZUMAB
Reset all filters
01 3SOLUTION
Reset all filters
01 32035-03-06
Patent Expiration Date : 2035-03-06
Date Granted : 2022-11-08
Brand Name : ULTOMIRIS
Patent Number : 2942165
Filing Date : 2015-03-06
Strength per Unit : 10mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2035-03-06
Date Granted : 2022-11-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-03-06
Date Granted : 2022-11-08
Brand Name : ULTOMIRIS
Patent Number : 2942165
Filing Date : 2015-03-06
Strength per Unit : 100 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2035-03-06
Date Granted : 2022-11-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-03-06
Date Granted : 2022-11-08
Brand Name : ULTOMIRIS
Patent Number : 2942165
Filing Date : 2015-03-06
Strength per Unit : 100 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2035-03-06
Date Granted : 2022-11-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF